Precipio, Inc. (PRPO)

6.03 -0.15 (-2.51%) At close: 04:00PM EDT

Precipio, Inc.

4 Science Park
3rd Floor
New Haven, CT 06511
United States
203 787 7888
https://www.precipiodx.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 51

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Ilan Danieli	Founder, President, CEO & Director	324.1k	N/A	1972
Dr. Ayman A. Mohamed M.D.	Chief Technology Officer	234.1k	N/A	1985
Mr. Matthew Gage	Chief Financial Officer	N/A	N/A	1967
Mr. Ahmed Zaki Sabet	Chief Operating Officer	229.03k	N/A	1987
Ms. Miri Chiko-Radomski	Chief Legal Counsel & People Officer	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.

Corporate governance

Precipio, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.